402 related articles for article (PubMed ID: 27109785)
1. Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.
Mantovani G; Spada A; Elli FM
Nat Rev Endocrinol; 2016 Jun; 12(6):347-56. PubMed ID: 27109785
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone resistance syndromes - Inactivating PTH/PTHrP signaling disorders (iPPSDs).
Elli FM; Pereda A; Linglart A; Perez de Nanclares G; Mantovani G
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):941-954. PubMed ID: 30665554
[TBL] [Abstract][Full Text] [Related]
3. PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance.
Linglart A; Fryssira H; Hiort O; Holterhus PM; Perez de Nanclares G; Argente J; Heinrichs C; Kuechler A; Mantovani G; Leheup B; Wicart P; Chassot V; Schmidt D; Rubio-Cabezas Ó; Richter-Unruh A; Berrade S; Pereda A; Boros E; Muñoz-Calvo MT; Castori M; Gunes Y; Bertrand G; Bougnères P; Clauser E; Silve C
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2328-38. PubMed ID: 23043190
[TBL] [Abstract][Full Text] [Related]
4. [Genes in the cAMP pathway causing skeletal dysplasia with or without hormonal resistance].
Silve C
Biol Aujourdhui; 2016; 210(3):167-170. PubMed ID: 27813477
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders.
Truelove A; Mulay A; Prapa M; Casey RT; Adler AI; Offiah AC; Poole KES; Trotman J; Al Hasso N; Park SM
Am J Med Genet A; 2019 Jul; 179(7):1330-1337. PubMed ID: 31041856
[TBL] [Abstract][Full Text] [Related]
6. PRKAR1A mutation affecting cAMP-mediated G protein-coupled receptor signaling in a patient with acrodysostosis and hormone resistance.
Nagasaki K; Iida T; Sato H; Ogawa Y; Kikuchi T; Saitoh A; Ogata T; Fukami M
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1808-13. PubMed ID: 22723333
[TBL] [Abstract][Full Text] [Related]
7. From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network.
Thiele S; Mantovani G; Barlier A; Boldrin V; Bordogna P; De Sanctis L; Elli FM; Freson K; Garin I; Grybek V; Hanna P; Izzi B; Hiort O; Lecumberri B; Pereda A; Saraff V; Silve C; Turan S; Usardi A; Werner R; de Nanclares GP; Linglart A
Eur J Endocrinol; 2016 Dec; 175(6):P1-P17. PubMed ID: 27401862
[TBL] [Abstract][Full Text] [Related]
8. Pseudohypoparathyroidism, acrodysostosis, progressive osseous heteroplasia: different names for the same spectrum of diseases?
Elli FM; Mantovani G
Endocrine; 2021 Jun; 72(3):611-618. PubMed ID: 33179219
[TBL] [Abstract][Full Text] [Related]
9. Inactivating PTH/PTHrP Signaling Disorders.
Mantovani G; Elli FM
Front Horm Res; 2019; 51():147-159. PubMed ID: 30641531
[TBL] [Abstract][Full Text] [Related]
10. Acrodysostosis: A new form of pseudohypoparathyroidism?
Silve C
Ann Endocrinol (Paris); 2015 May; 76(2):110-2. PubMed ID: 25890446
[No Abstract] [Full Text] [Related]
11. Evaluating the variety of GNAS inactivation disorders and their clinical manifestations in 11 Chinese children.
Chang G; Li Q; Li N; Li G; Li J; Ding Y; Huang X; Shen Y; Wang J; Wang X
BMC Endocr Disord; 2022 Mar; 22(1):70. PubMed ID: 35296306
[TBL] [Abstract][Full Text] [Related]
12. Acroscyphodysplasia as a phenotypic variation of pseudohypoparathyroidism and acrodysostosis type 2.
Mitsui T; Kim OH; Hall CM; Offiah A; Johnson D; Jin DK; Toh TH; Soneda S; Keino D; Matsubayashi S; Ishii T; Nishimura G; Hasegawa T
Am J Med Genet A; 2014 Oct; 164A(10):2529-34. PubMed ID: 25044890
[TBL] [Abstract][Full Text] [Related]
13. Genetics and epigenetics of parathyroid hormone resistance.
Bastepe M
Endocr Dev; 2013; 24():11-24. PubMed ID: 23392091
[TBL] [Abstract][Full Text] [Related]
14. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
Turan S
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
[TBL] [Abstract][Full Text] [Related]
15. What to consider when pseudohypoparathyroidism is ruled out: iPPSD and differential diagnosis.
Pereda A; Garin I; ; Perez de Nanclares G
BMC Med Genet; 2018 Mar; 19(1):32. PubMed ID: 29499646
[TBL] [Abstract][Full Text] [Related]
16. Fourteen-year follow-up of a child with acroscyphodysplasia with emphasis on the need for multidisciplinary management: a case report.
Kartalias K; Gillies AP; Peña MT; Estrada A; Bulas DI; Ferreira CR; Tosi LL
BMC Med Genet; 2020 Sep; 21(1):189. PubMed ID: 32993552
[TBL] [Abstract][Full Text] [Related]
17. Different pattern of epigenetic changes of the GNAS gene locus in patients with pseudohypoparathyroidism type Ic confirm the heterogeneity of underlying pathomechanisms in this subgroup of pseudohypoparathyroidism and the demand for a new classification of GNAS-related disorders.
Brix B; Werner R; Staedt P; Struve D; Hiort O; Thiele S
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1564-70. PubMed ID: 24878042
[TBL] [Abstract][Full Text] [Related]
18. Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series.
Elli FM; Barbieri AM; Bordogna P; Ferrari P; Bufo R; Ferrante E; Giardino E; Beck-Peccoz P; Spada A; Mantovani G
Bone; 2013 Oct; 56(2):276-80. PubMed ID: 23796510
[TBL] [Abstract][Full Text] [Related]
19. Clinical review: Pseudohypoparathyroidism: diagnosis and treatment.
Mantovani G
J Clin Endocrinol Metab; 2011 Oct; 96(10):3020-30. PubMed ID: 21816789
[TBL] [Abstract][Full Text] [Related]
20. GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.
Lemos MC; Thakker RV
Hum Mutat; 2015 Jan; 36(1):11-9. PubMed ID: 25219572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
